To further confirm the function of NAT10 in the chemoresistance in HCC, we evaluated the IC50 of doxorubicin and oxaliplatin in Huh7-NAT10 shRNA-1, Huh7-NAT10 shRNA-2 or Huh7-control shRNA cells. This evidence concerns the gene NAT10 and hepatocellular carcinoma.